Base Editing CAR T Cells: Leukemia Treatment Advance

In patients with T cell acute lymphoblastic leukemia, base-edited CAR T cells — capable of destroying leukemic T cells while they themselves are protected — induced remission and allowed progression to stem-cell transplantation.